Suppression of murine allergic airway disease by IL-2:anti-IL-2 monoclonal antibody-induced regulatory T cells. - Wikidata - wikimedia - TriplyDB

Suppression of murine allergic airway disease by IL-2:anti-IL-2 monoclonal antibody-induced regulatory T cells.

Suppression of murine allergic airway disease by IL-2:anti-IL-2 monoclonal antibody-induced regulatory T cells.

http://www.wikidata.org/entity/Q37251467

about

Application of IL-2 therapy to target T regulatory cell function Low-dose interleukin-2 therapy: a driver of an imbalance between immune tolerance and autoimmunity Subsets of regulatory T cells and their roles in allergy Pulmonary fibrosis: pathogenesis, etiology and regulation LPS nephropathy in mice is ameliorated by IL-2 independently of regulatory T cells activity IL-2-Mediated In Vivo Expansion of Regulatory T Cells Combined with CD154-CD40 Co-Stimulation Blockade but Not CTLA-4 Ig Prolongs Allograft Survival in Naive and Sensitized Mice Low-dose interleukin-2 promotes STAT-5 phosphorylation, Treg survival and CTLA-4-dependent function in autoimmune liver diseases IL-2/anti-IL-2 antibody complexes show strong biological activity by avoiding interaction with IL-2 receptor alpha subunit CD25 Exercise training, lymphocyte subsets and their cytokines production: experience of an Italian professional football team and their impact on allergy.Improved IL-2 immunotherapy by selective stimulation of IL-2 receptors on lymphocytes and endothelial cells Immune pathways for translating viral infection into chronic airway disease.Ischemic preconditioning in the liver is independent of regulatory T cell activity.Regulatory T cells in many flavors control asthma IL-2/anti-IL-2 antibody complex treatment inhibits the development but not the progression of herpetic stromal keratitis.Exogenous IL-2 controls the balance in Th1, Th17, and Treg cell distribution in patients with progressive rheumatoid arthritis treated with TNF-alpha inhibitors.Host epithelial-viral interactions as cause and cure for asthma.Central role for interleukin-2 in type 1 diabetes.Regulatory T cells expressing granzyme B play a critical role in controlling lung inflammation during acute viral infection.Th2 Cytokines Augment IL-31/IL-31RA Interactions via STAT6-dependent IL-31RA Expression IL-2/α-IL-2 Complex Treatment Cannot Be Substituted for the Adoptive Transfer of Regulatory T cells to Promote Bone Marrow Engraftment.IL-2 and IL-4 stimulate MEK1 expression and contribute to T cell resistance against suppression by TGF-beta and IL-10 in asthma.IL-2/IL-2Ab complexes induce regulatory T cell expansion and protect against proteinuric CKD.Mast cell interleukin-2 production contributes to suppression of chronic allergic dermatitis.Low-level regulatory T-cell activity is essential for functional type-2 effector immunity to expel gastrointestinal helminths.Role of cytokines in thymus- versus peripherally derived-regulatory T cell differentiation and function Short-term intratracheal use of PEG-modified IL-2 and glucocorticoid persistently alleviates asthma in a mouse model.In vivo expansion of T reg cells with IL-2-mAb complexes: induction of resistance to EAE and long-term acceptance of islet allografts without immunosuppression The development and function of regulatory T cells.T regulatory cells: an overview and intervention techniques to modulate allergy outcome Anti-CD20 as the B-Cell Targeting Agent in a Combined Therapy to Modulate Anti-Factor VIII Immune Responses in Hemophilia a Inhibitor Mice Airway autoimmune responses in severe eosinophilic asthma following low-dose Mepolizumab therapy Targeting Treg cells in situ: emerging expansion strategies for (CD4(+)CD25(+)) regulatory T cells.Potential and limitations of regulatory T-cell therapy in solid organ transplantation.TSLP directly impairs pulmonary Treg function: association with aberrant tolerogenic immunity in asthmatic airway.The promise of low-dose interleukin-2 therapy for autoimmune and inflammatory diseases.IL-6 controls susceptibility to helminth infection by impeding Th2 responsiveness and altering the Treg phenotype in vivo.Treg-Centric View of Immunosuppressive Drugs in Transplantation: A Balancing Act.Dying to protect: cell death and the control of T-cell homeostasis.IL-2 complex treatment amplifies CD8+ T cell mediated immunity following herpes simplex virus-1 infection.Transcription factor c-Rel is indispensable for generation of thymic but not of peripheral Foxp3+ regulatory T cells.

P2860

Q26827327-6B9E6CAB-1171-4DDC-A7BC-2FA7AB6AAB02 Q27008200-3CBD9F3F-724C-4C42-8D8C-620CAD5938A1 Q27024217-92AEBDFA-186F-4E8B-B115-B09A66F2DC6D Q28388425-3EA11F8A-FCA9-4D7F-9F30-C6F93DEDE780 Q28544395-8D80D48E-1DF2-4609-B082-EDF860F21AC5 Q33586165-4AEED06C-CFE8-4396-8F39-0F6B10319D03 Q33650813-BA07B695-8ACA-4CFE-9ECA-32CDC5202385 Q33719745-020A968A-D687-44BE-A8F0-F300F9AE8717 Q33891349-9A4ECD67-3350-46CE-85BE-73A951AB54B0 Q33977597-61F5D9BB-15BA-4BA4-BE5E-247A65ADE4B1 Q34440425-73528C75-CFED-4E66-B3E8-23F4CACCF0F8 Q34490320-91A576F9-E9B4-4BA0-BFF2-3AC8C01592D9 Q34574231-23D30231-746C-407E-A4A5-D51809755028 Q34749483-5945A105-4DFC-428B-99C4-B4650808EA6D Q35132706-5D718CFB-9BF3-49A4-915A-BABD74ED7C77 Q35186305-A5B614AA-6CD8-4BC2-B99E-AF5F3163E33A Q35612414-E4F94335-B5E3-4BF1-9C9D-ADE32D8284EF Q35765491-94B7B383-AA43-496D-83D2-D17991669627 Q35861021-ABED5E69-A295-412E-AA4B-2139F810C6F2 Q35885490-F0E5DD64-D78C-4F12-AB85-557639C676F7 Q36009860-EE9EC6B3-631C-409E-8D38-45E4879534BF Q36109177-F634F6C7-9C59-43C9-9F93-3BC7D3AD462B Q36205829-D633D415-B7C7-48D8-A313-1D6D07902386 Q36367506-2635A0D4-BE50-4BDE-B489-7AC886877736 Q36938226-81E1795A-1BDF-4DD3-97DD-C797AD7023B0 Q37177130-179BEE20-AC2E-4140-8555-0BEB0FC4610D Q37273329-C9EF7D68-8145-4050-A1C3-6B3ABC98250F Q37274250-5839FA29-1F87-4652-8EB5-858A4DA55BED Q37414418-E248322F-6583-48DC-9D63-1549B9591A4A Q37434315-7067DC4F-F0EA-41C0-8401-B8C79E91B1C6 Q37563901-9FF0B661-8CEE-47F6-8441-2D04C924AC8E Q37595721-AF2D6AFA-46F8-4975-A18C-A3704634F5EB Q38235166-E798F03F-35D2-4FD9-AEFF-D452ACC027B4 Q38259557-895DE831-1221-4B13-92BB-93F78345C8CC Q38424758-659D48C6-FAF0-45E1-BCFC-CA889B972AB5 Q38843572-99A74C0C-51E9-40DE-963F-7AAB8B4264E2 Q38942832-4F9D5806-AD4D-40F1-AE42-E2CA745FDC68 Q39277476-A597CB73-3752-4F45-9B36-863A1BFFAF41 Q40443562-0D039DF7-F8EE-49F4-B912-FE6ED2623652 Q41592849-65472C98-2FD2-4B6D-B337-4104FF5B84D4

P2860

Suppression of murine allergic airway disease by IL-2:anti-IL-2 monoclonal antibody-induced regulatory T cells.

http://www.wikidata.org/entity/Q37251467

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh

2008年學術文章

@zh-hant

name

Suppression of murine allergic ...... dy-induced regulatory T cells.

@en

Suppression of murine allergic ...... dy-induced regulatory T cells.

@nl

type

label

Suppression of murine allergic ...... dy-induced regulatory T cells.

@en

Suppression of murine allergic ...... dy-induced regulatory T cells.

@nl

prefLabel

Suppression of murine allergic ...... dy-induced regulatory T cells.

@en

Suppression of murine allergic ...... dy-induced regulatory T cells.

@nl

P1433

Q37251467-D655CBEF-63BD-412B-8C7B-A0B18980FEE7

P1476

Q37251467-4EAE76C6-5245-4550-A9E9-004C4576091C

P2093

Q37251467-1BB4456D-00D0-4989-BD3A-996BE526E392

Q37251467-38212FFF-E377-4224-9370-9335F46ABA46

Q37251467-5578580D-6006-4E43-BD2F-17D4B4B6882C

Q37251467-68F9DD44-4149-4376-B007-44CE72D520C7

Q37251467-BE66095A-FC25-43B9-897F-602FEBAFA46F

Q37251467-DE79DFBB-1C14-4DB7-B75F-666005739538

P2860

Q37251467-09A248E1-3898-48DC-8037-458545F342A3

Q37251467-0B25C016-D7BB-49CC-822D-F976DAF36E96

Q37251467-0C276819-97E7-404C-AF76-F70B92A3B859

Q37251467-101EAA2F-886D-4EE2-8C3A-1FB302A007AC

Q37251467-106400E1-B171-47EF-9C32-A4E32A81312D

Q37251467-1077BDD9-B26E-4B76-9E8C-8ED36C8E5AC2

Q37251467-130F17D5-7283-4C40-8355-F6653354B289

Q37251467-1591E55C-A87D-457C-9434-C5C57BD8B8FF

Q37251467-18E63E45-A04C-4059-8362-9774F4A6D3AE

Q37251467-1988ACDC-4F47-470C-9C2D-CB1228C08D5F

P304

Q37251467-76E7556F-E93C-4F1C-867D-257E5D2A9C9F

P31

Q37251467-28DC31E4-59A5-4165-9779-89C3C23F8BC0

P356

Q37251467-72F525A4-22E4-4110-BF21-39B2791D2E45

P407

Q37251467-4F2F3541-E62A-46D8-8524-A9F62270C17E

P433

Q37251467-CD497405-1EA7-4958-84FC-B03BF6CA34C5

P478

Q37251467-02A125BD-7F1E-4C20-B6AA-CF0CDE274D84

P577

Q37251467-591CC46D-80E7-4B6C-996A-C4C3C534F7DB

P5875

Q37251467-93D4921C-6E77-4B3E-8431-A9DA225BF498

P698

Q37251467-6212591E-6C32-4B89-A129-0C6C2FC0AF48

P921

Q37251467-DF539155-6FB3-44D6-AA64-7F0D7FE7D4A7

P932

Q37251467-38ABC886-9BA1-433C-ADE7-17D58A6E36D3

P356

JIMMUNOL.181.10.6942

P1433

Journal of Immunology

P1476

Suppression of murine allergic ...... dy-induced regulatory T cells.

@en

P2093

Allen Cheever

http://www.w3.org/2001/XMLSchema#string

John T Pesce

http://www.w3.org/2001/XMLSchema#string

Mark S Wilson

http://www.w3.org/2001/XMLSchema#string

Robert W Thompson

http://www.w3.org/2001/XMLSchema#string

Thirumalai R Ramalingam

http://www.w3.org/2001/XMLSchema#string

Thomas A Wynn

http://www.w3.org/2001/XMLSchema#string

P2860

Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse

Defective CD4+CD25+ regulatory T cell functioning in collagen-induced arthritis: an important factor in pathogenesis, counter-regulated by endogenous IFN-gamma

Resolution of airway inflammation and hyperreactivity after in vivo transfer of CD4+CD25+ regulatory T cells is interleukin 10 dependent.

Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells

IL-35 is a novel cytokine with therapeutic effects against collagen-induced arthritis through the expansion of regulatory T cells and suppression of Th17 cells

The inhibitory cytokine IL-35 contributes to regulatory T-cell function

Expression of interleukin-10 in intestinal lymphocytes detected by an interleukin-10 reporter knockin tiger mouse

A function for interleukin 2 in Foxp3-expressing regulatory T cells

Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene

CD4+CD25+ T regulatory cells, immunotherapy of cancer, and interleukin-2.

P304

6942-6954

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4049/JIMMUNOL.181.10.6942

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

181

http://www.w3.org/2001/XMLSchema#string

P577

2008-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23448486

http://www.w3.org/2001/XMLSchema#string

P698

18981114

http://www.w3.org/2001/XMLSchema#string

P921

P932

2706157

http://www.w3.org/2001/XMLSchema#string